- Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia
- Researchers test whether diabetes drug can help Parkinson’s patients
- Acute optic neuritis: a review and proposed protocol
- Hippocampal subfield size predicts the precision of memory recall
- Immune system implicated in dementia development
- UCL and Chiesi Group announce partnership to develop a novel therapeutic for birth asphyxia
- Professor Golay made a Fellow of the ISMRM
- The new Leonard Wolfson Experimental Neurology Centre (LWENC) has opened for clinical studies and trials
- Professor Rees wins UCLU Student Choice Teaching Award
- New epilepsy treatment offers ‘on demand’ seizure suppression
- Professor Tabrizi and Professor Price elected to Fellowship of the Academy of Medical Sciences.
- Professor Dolan and Professor Friston elected to EMBO membership
- Vitamin B3 treatment for ataxia shows promise in first human trial
- Teaching Awards 2014
- Light-activated neurons from stem cells restore function to paralysed muscles
- UCL and Max Planck Society invest €5m to open world’s first computational psychiatry centre
- Successful launch of new annual leading edge neurology course
- Statins could help control MS
- Professor Hardy awarded Thudichum Medal by Biochemical Society
- Population Screening for vCJD Using a Novel Blood Test
- Chief Medical Officer appoints Professor Rossor as NIHR National Director for Dementia Research
- New partnership between UCLP brain tumour scientists and Brain Tumour Research
- Professor Hardy awarded Dan David Prize for work on the amyloid gene encoding APP
- NIHR award £650,000 for research into rare neurodegenerative and neuromuscular diseases
- Lowering levels of toxic protein reverses abnormalities in cells from patients with Huntington's disease
- Major initiative in understanding synaptic basis of neuropsychiatric disease
- Visit to the Berlin School of Mind and Brain
- Institute of Neurology ranked as the world’s top institution for epilepsy research.
- Predicting age at onset in SCA1 : does size matter?
- UCL takes the lead with £8.5m funding for dementia research
- Secretary of State visits leading dementia research projects
- Riboflavin Treatment for Childhood onset Motor Neuron Disease
- Dreading pain can be worse than pain itself
- Different gene expression in male and female brains helps explain differences in brain disorders
- New £20m centre pioneers first-in-man trials for neurodegenerative diseases
- RNA build-up linked to dementia and motor neuron disease
- Researchers estimate one in 2,000 people in the UK carry variant CJD proteins
- Professor Alan Thompson discusses Atlas of MS on Lancet News
- Wellcome Trust Principal Fellowship award to explore neural coding with the tripartite synapse
- Marsden's Book of Movement Disorders wins Neurology first prize at the 2013 BMA Book Awards
- Scientists develop refined diagnostic tool for inherited dementias
- Genetic mutations linked to Parkinson's Disease
- P-glycoprotein over-activity and drug resistance in temporal lobe epilepsy
- New Yale-UCL collaboration in brain aneurysm genetics
- ‘Risky’ stroke prevention procedure may be safe in some patients
- The Michael J. Fox Foundation awards grant for Exenatide research
- Institute Professor leads cross-disciplinary study on use of glucose in detecting cancer.
- Irreversible tissue loss seen within 40 days of spinal cord injury
- From Bedside to Bench in the Institute’s MRC Centre for Neuromuscular Diseases
- Centralising acute stroke services has saved more than 400 lives since 2010
- Rapid Response Innovation Award from The Michael J. Fox Foundation
- Predicting Language Outcome and Recovery After Stroke (PLORAS) project launches new website
- BRC awards over £500k to neuroscience projects
- ABTA Winners
- Diabetes drug could help treat Parkinson's Disease
- Clinical trials are vital tools in stroke research
- New gene identified for Dominant Congenital Spinal Muscular Atrophy and Hereditary Spastic Paraparesis
- Teaching Awards 2013
- 14th Annual Queen Square Symposium
- TRACK-HD study identifies early predictors of disease progression in Huntington’s disease
- The Great Brain Experiment: crowdsourcing data on how we think and act
- Psychogenic diseases linked to abnormal brain activity
- Human Brain Project wins major EU funding
- Gene mutation causes familial form of cranio-cervical dystonia
- Professor Ray Dolan awarded prestigious Klaus Joachim Zülch Prize
- Professor Dimitri Kullmann elected Editor of Brain
- IoN News Archive (2012)
- IoN News Archive (2011)
- IoN News Archive (2010)
- IoN News Archive (2009)
Published: Dec 10, 2013 2:49:43 PM
Published: Jul 16, 2014 5:42:14 PM
Published: Jan 16, 2014 12:32:49 PM
Published: May 11, 2013 3:39:00 PM
Published: Sep 16, 2013 1:37:21 PM
Immune system implicated in dementia development
18 June 2014
The immune system and body’s response to damaged cells play a key role in the development of frontotemporal dementia (FTD), finds new research led by the UCL Institute of Neurology.
These findings will enable researchers to develop new treatments that target the body’s response to damaged cells. FTD is the second most common form of young-onset dementia after Alzheimer’s disease. The disease is caused when nerve cells in the frontal and/or temporal lobes of the brain die and the pathways connecting them change. In the majority of cases, the disease is not inherited.
We are trying to understand what causes or predisposes people to the non-inherited form of FTD. Even though the disease is sporadic (not inherited), there are genetic pre-dispositions. This study is the type where we can find those pre-disposing factors.
Professor John Hardy, co-leader of the study, NIHR Queen Square Dementia Biomedical Research Unit
The study, published in Lancet Neurology, involved more than 40 research groups from Europe, Australia and the US who contributed several thousand FTD cases for analysis.
study found evidence of two key processes driving FTD development.
The first is an out-of-control inflammatory process in the brain and the second is a lysosomal problem. Lysosomes are parts of the cell which are responsible for digesting damaged proteins. What we think this is telling us is that these damaged proteins are overwhelming the damage response part of the cell.
Professor John Hardy
This finding in FTD raises interesting parallels with Parkinson’s Disease, another neurodegenerative disease that has been linked to similar processes.
These findings provide the basis for future genetic and functional studies aimed at replicating these results, as well as shedding light on the molecular mechanisms that contribute to the pathogenesis of the disease
Lead author Dr Raffaele Ferrari
The study shows the value of international collaboration to amass the data needed. It also shows how much can be learned from one neurodegenerative disease which is of value to understanding others.
Professor Martin Rossor, Director of the NIHR Queen Square Dementia Biomedical Research Unit and NIHR National Research Dementia Professor
- Ferrari, R. et al. (2014) Frontotemporal dementia and its subtypes: a genome-wide association study Lancet Neurology, Volume 13, Issue 7, July 2014, Pages 686–699. DOI: 10.1016/S1474-4422(14)70065-1
- National Institute for Health Research University College London Hospitals Biomedical Research Centre
- Diagram showing areas of the brain affected by FTD
Page last modified on 18 jun 14 13:53